A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61“) Mice

Author： Chesselet Marie-Francoise  

Publisher： Springer Publishing Company

ISSN： 1933-7213

Source： Neurotherapeutics, Vol.9, Iss.2, 2012-04, pp. : 297-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astrocyte Delivery of Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease

By Cunningham L.A.   Su C.  

Experimental Neurology, Vol. 174, Iss. 2, 2002-04 ,pp. : 230-242

Elsevier

Access to resources Recommend Favorite

Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease

By Mandel R.J.   Snyder R.O.   Leff S.E.  

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 205-214

Elsevier

Access to resources Recommend Favorite

Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease

By Doo Ah-Reum   Kim Seung-Tae   Kim Seung-Nam   Moon Woongjun   Yin Chang Shik   Chae Younbyoung   Park Hun-Kuk   Lee Hyejung   Park Hi-Joon  

Neurological Research, Vol. 32, Iss. 1, 2010-02 ,pp. : 88-91

Maney Publishing

Access to resources Recommend Favorite

First‐line treatment in Parkinson's disease

By  

PRACTICAL NEUROLOGY, Vol. 5, Iss. 3, 2005-06 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

The rotenone model of Parkinson's disease

By Perier C.   Bove J.   Vila M.   Przedborski S.  

Trends in Neurosciences, Vol. 26, Iss. 7, 2003-07 ,pp. : 345-346

Elsevier

Access to resources Recommend Favorite